Articles tagged with Cancer Patients
Researchers have developed a novel compound targeting STAT5, which selectively disrupts its activation and gene transcription, impairing AML cell proliferation. The compound showed efficacy in patient-derived AML cell lines and freshly isolated patient samples, indicating its potential as a new treatment option for leukemia.
A phase I clinical trial has shown some promise for an investigational compound designed to block a hyperactive cell growth signal in advanced melanoma and other cancers. Three patients experienced partial responses to the treatment, similar to response rates seen with other treatments such as MEK inhibitors.
The studies reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses. Larotrectinib had rapid, potent, and durable anti-tumor activity in children and adults with solid tumors and TRK fusions.
A phase 1/2 trial of larotrectinib found that three-quarters of patients with advanced cancers responded to the treatment, which targets a specific genetic mutation. The therapy has shown promise in treating pediatric patients with TRK-positive cancer, including infantile fibrosarcoma, and offers a potential cure for some cases.
Researchers developed a method combining diffusion-weighted MRI with intelligent image analysis to detect malignant changes in breast tissue. The new method reduced false positive findings by 70% and accurately identified malignant tumors in 98% of cases.
A study found that patients with advanced cancer were less capable of making treatment decisions than healthy adults, but doctors often overestimated their competence. The research suggests a shift in patient-doctor relationships, emphasizing the importance of respecting patient autonomy while ensuring decision-making capacity.
Researchers developed a liquid biopsy test to profile cancer genomes from blood and predict survival outcomes for patients with metastatic triple negative breast cancer. The study found that 64% of patients had more than 10% tumor DNA, correlated with poor survival outcomes.
A new study published in JAMA Surgery found that breast cancer patients who undergo mastectomy with or without immediate reconstruction tend to be less satisfied than expected with their physical and sexual health post-surgery. Women who choose immediate reconstruction overestimated their satisfaction with appearance, while those who d...
Researchers have identified a unique packaging method of genes in early embryos that helps regulate their expression. This study provides insights into the mechanisms controlling embryonic development, which may impact gene expression and inheritance, including predisposition to diseases like cancer.
Scientists have discovered that the Huntington's gene is toxic to cancer cells due to its repetitive RNA sequences, which can be harnessed for a novel cancer treatment approach. Researchers hope to develop a short-term treatment to kill cancer cells without causing neurological issues associated with Huntington's disease.
Researchers at Cold Spring Harbor Laboratory have discovered that a widely-studied cancer gene called MELK does not play a crucial role in cancer cell growth. The team's findings suggest that inherent flaws in scientific techniques used to link MELK to cancer led to the error.
A study combining axitinib and pembrolizumab found the treatment to be tolerable and doubling efficacy in patients with advanced kidney cancer. Over 90% of patients exhibited tumor shrinkage, keeping disease under control for over 20 months.
Teleconsulting is crucial for rare cancers like sarcomas, which require specialized expertise. EURACAN, a European Reference Network, aims to provide timely diagnosis and treatment through referral networks.
A new hybrid-capture sequencing assay has been established as the method of choice for detecting 'actionable' gene mutations in lymphoid cancer, with a high accuracy rate of 91%. The assay can be implemented by clinical laboratories into routine diagnostic workflows.
Research from the Francis Crick Institute discovered that immune cells called Natural Killer cells accumulate in tumours and release chemicals attracting specialised dendritic cells. Genes associated with these cells correlated with cancer patient survival rates, suggesting a new basis for immunotherapies.
Scientists have successfully grown human eggs in a laboratory from their earliest stage to full maturity, paving the way for improved fertility treatments. The advance aims to safeguard the fertility of girls with cancer ahead of potentially harmful medical treatment.
One hundred high school students from 28 states have been named winners in the third year of PBS' and Stand Up To Cancer's Emperor Science Award program. The recipients will work with a university scientist on a multi-week cancer research project, receive a Google Chromebook computer, and a $1,500 stipend.
The marbled crayfish, a single female ancestor of all Marmorkrebs specimens, exhibits epigenetic mechanisms that enable rapid adaptation to various environments without genetic variation. This clonal genome evolution shares similarities with tumor development, where environmental factors influence gene regulation and adaptation.
Researchers identified unique mitochondrial defects and alterations in metabolic gene expression associated with aggressive triple-negative breast cancers. The findings provide new molecular biomarkers to identify patients at risk for metastasis and offer potential therapeutic targets.
Researchers Jos Jonkers and Helen Piwnica-Worms receive a grant to investigate how the immune system recognizes breast cancer. They will use imaging mass cytometry and patient-derived models to devise new treatment combinations, accelerating promising therapies to patients.
Exercising regularly before surgery for lung cancer halves the complication rate afterwards, with a 48% reduction in postoperative complications. Exercise also reduces the length of hospital stay by almost three days, according to a pooled analysis of 13 clinical trials involving 806 participants.
Researchers at UT Southwestern's Simmons Cancer Center have made a historic breakthrough in CAR-T therapy for acute lymphoblastic leukemia (ALL) in children and young adults. Eighty-one percent of patients treated with CAR-T therapy went into remission, offering new hope for those previously untreatable.
A new web-based stress management program has been shown to significantly improve the quality of life and reduce distress in newly diagnosed cancer patients. The online program, developed by researchers from the University of Basel, provides patients with information, exercises, and strategies to manage their condition.
Seven multi-disciplinary teams will investigate immune system response to cancers, exploring factors such as DNA mismatch repair, tumor-specific proteins, and cytokine function. The teams will use machine learning expertise and access to terabytes of data to develop new treatments with less damage.
The CONCORD-3 study reveals global improvement in cancer survival, with some countries experiencing significant gains, while others lag behind. However, disparities in childhood cancers and incomplete data in Africa limit the accuracy of these findings.
A recent study presented at the American Stroke Association's International Stroke Conference found that cancer patients with stroke are less likely to receive standard clot-busting medication compared to those without a malignancy. The use of newer procedures to mechanically remove clots, however, shows a similar trend in both groups.
A new study provides guidelines for assessing the severity of head and neck cancers by counting malignant lymph nodes, which are found to be a key factor in predicting patient survival. The number of positive nodes can categorize patients into distinct groups with varying outcomes.
The foundation awarded grants to early career scientists with 'high-risk/high-reward' ideas who lack preliminary data, aiming to significantly impact cancer prevention, diagnosis, and treatment. The recipients will use prebiotics to manipulate the microbiota, develop novel degraders for targeted therapies, and investigate tumor T cells...
Researchers found that even mild depressive symptoms were associated with poorer overall survival in patients with head and neck cancer. The study indicates that patients should be screened for depressive symptoms at diagnosis and treated promptly to improve treatment outcomes.
The VTX-1 Liquid Biopsy System is a commercial, automated instrument that isolates clinically relevant CTC populations directly from whole blood. It achieves high recovery rates of spiked breast and lung cancer cell lines, with purities as low as <100 white blood cells per mL of processed blood.
A study found that pediatric cancer patients' microbiome diversity can predict the risk of developing blood infections, suggesting a link between gut health and bloodstream infections. The researchers argue that prevention and treatment strategies may depend on the source of infection, rather than relying solely on central line hygiene.
A University of Colorado Cancer Center study found low post-treatment mortality rates for both surgery and targeted radiation in early-stage lung cancer patients. Patients over 80 years old showed significantly higher mortality rates with surgery compared to targeted radiation.
A long-term health study found a 24% increase in cancer risk among participants with severe periodontitis compared to those with mild to no periodontitis. The highest risk was observed in cases of lung cancer, followed by colorectal cancer.
A new mathematical tool, based on Bayes' Theorem, was developed to validate and improve methods for interpreting clinical genetic test results. The tool assessed the rigor of widely-used approaches and found that a system of 18 rules is statistically sound and objectively strong.
Researchers developed CancerSEEK, a noninvasive blood test detecting cancer mutations and protein biomarkers in the blood. The test detected cancer with a sensitivity of 69-98% and was 99% specific.
Researchers have identified a new precision medicine approach for metastatic pancreatic cancer, analyzing tumor RNA to match patients with targeted drugs. The approach has shown clinical responses in three of four patients, targeting 'master regulator proteins' responsible for cancer cell survival.
A new review examines the quality-of-life consequences of genetic testing and risk-reducing surgery, finding that procedures can decrease cancer anxiety but are associated with short- and long-term complications.
A Mayo Clinic study published in the New England Journal of Medicine found that patients with monoclonal gammopathy of undetermined significance are at risk of progressing to multiple myeloma or a related cancer even after 30 years. The overall risk of progression is relatively small, but it persists indefinitely.
3D organoid models derived from patient cells can guide clinical decision-making for individuals with gastrointestinal cancers. Researchers hope these models will predict treatment response and increase response rates by finding the best treatment combination for every patient.
A gene enhancer cluster, BENC, plays a crucial role in regulating Myc activity and cancer growth. The discovery suggests BENC as a potential target for novel therapies against blood cancer.
A study highlights the need for better training and education in the dental community to discuss HPV prevention methods with patients. Most dentists don't address HPV-related oropharyngeal cancers due to lack of knowledge and communication skills.
A clinical trial investigates whether dietary and exercise interventions can decrease AGEs, which have been linked to cancer, in prostate cancer survivors. Preliminary data suggest that AGEs may be a better biomarker for lifestyle changes than previously used markers.
A recent study has found that cancer patients given fluids at the end-of-life stage live significantly longer than those who don't receive such treatment. This results in an average of one-and-a-half more days of life, as well as better symptom control and minimal side effects.
A retrospective analysis of 73 lung squamous cell carcinoma patients found that higher body mass index and younger age were linked with longer progression-free survival. Patients with a better response to treatment also had longer overall survival.
Researchers found that DNA repair-related biomarkers, including BRF1, BRCA1/2, and MPO, can predict outcomes in gastric cancer patients who abuse alcohol. These biomarkers were associated with disease recurrence, survival rates, and response to chemotherapy.
A new study reveals significant healthcare disparities among patients aged 80 and older with advanced lung cancer. African Americans and those from lower-income areas are more likely to not receive standard care therapy, leading to poorer outcomes. In contrast, patients receiving standard treatment live longer.
New research identifies characteristics of women who need extra support to self-manage their lymphedema, highlighting the importance of a 'stepped-care' approach. Advances in imaging techniques and technologies offer opportunities for improved patient monitoring and control.
Researchers found that germline variations in the tumor suppressor gene TP53 predispose children to develop leukemia and increase their chances of developing a second cancer. The variants are associated with reduced gene activity and were five times more frequent in pediatric ALL patients than those without the disease.
A team of researchers is developing complex computer models to predict how cancer will progress in individual patients. They use advanced computing resources, including those at the Texas Advanced Computing Center, to analyze patient-specific data from imaging tests and biopsies, as well as other factors.
A recent study found that smokers who use e-cigarettes tend to smoke less and have increased quit attempts, making them a potentially valuable tool for quitting smoking. The study also showed that higher-dose e-cigarettes had stronger outcomes, with participants smoking an average of 37% fewer cigarettes.
A study published in the American Journal of Public Health found that Medicaid expansion led to a significant increase in early-stage cancer diagnoses, particularly among those aged 35-54. The research suggests that public health insurance may increase cancer detection, resulting in fewer cancer deaths and better patient outcomes.
A study by the University of Houston found that over half of young cancer patients reported problems with sexual function. The probability of reporting sexual dysfunction increased over time, affecting 53% of participants two years after diagnosis. Relationships and psychological distress also played a role in sexual health.
Researchers developed an algorithm using smartphone data to detect worsening symptoms in cancer patients, allowing for early intervention and improved quality of life. The study enrolled 14 patients undergoing chemotherapy treatment, showing 88% accuracy in identifying high-symptom days.
Researchers have discovered that T cells with a protein called CD26 on their surface are highly effective against aggressive solid tumors. These cells, previously overlooked in cancer immunotherapy, can resist apoptosis and repopulate after infusion, making them ideal for adoptive cell transfer therapy.
A new study found that factors such as persistent symptoms, comorbidities, leisure-time physical activity, and financial challenges affect health-related quality of life in older adults with cancer. The research highlights the importance of comprehensive care that addresses these factors to improve outcomes for this vulnerable population.
The ESMO Position Paper emphasizes the need for patient-centered care in cancer treatment, addressing physical, psychological, social, and spiritual needs. It calls for increased awareness, research, education, and resources for supportive and palliative care.
Researchers present promising results from clinical trials suggesting patients with blood disorders and several types of cancer will soon have expanded treatment options. The studies show significant breakthroughs in reducing risks during rare blood disorders, such as thrombotic thrombocytopenic purpura, and improving treatment for mul...
Researchers have invented a method to detect tiny tumors and track their spread using light-emitting nanoprobes, potentially leading to earlier cancer detection and more precise treatment. The technology has shown better results than magnetic resonance imaging (MRI) in detecting small cancerous lesions.
Researchers developed a simple MRI technique to analyze brain tumors, finding that immune reactive cells around the tumor are associated with longer patient survival. This non-invasive method could provide an easier way for doctors to prescribe the most appropriate cancer treatment.
Researchers propose a revised cancer staging approach that incorporates liquid biopsy to improve diagnosis and treatment accuracy. The new system has shown promising results in guiding cancer care, particularly in detecting early-stage cancer and tracking treatment response.